Patents Assigned to Cyberonics, Inc.
-
Publication number: 20180200511Abstract: According to aspects of the present disclosure, an implantable pulse generator includes a housing, a header, and a retainer device. The housing includes circuitry and a battery. The header is coupled to the housing and includes a bore configured to receive an end of a lead, and a passage disposed transverse to the bore and extending between an exterior surface of the header and an anchor cavity that extends into the header from the bore. The header supports at least one electrical contact within the bore coupled to the circuitry. The retainer device includes a looped member arranged within the bore, a proximal end extending at least partially into the passage, and anchored at a distal end by the anchor cavity.Type: ApplicationFiled: March 13, 2018Publication date: July 19, 2018Applicant: Cyberonics, Inc.Inventors: Rajesh Ramesh, David L. Thompson, Steven W. Allis
-
Publication number: 20180200515Abstract: A method for managing bradycardia through vagus nerve stimulation is provided. An implantable neurostimulator configured to deliver electrical therapeutic stimulation in both afferent and efferent directions of a patient's cervical vagus nerve is provided. An operating mode is stored, which includes parametrically defining a maintenance dose of the electrical therapeutic stimulation tuned to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. The maintenance dose is delivered via a pulse generator through a pair of helical electrodes via an electrically coupled nerve stimulation therapy lead independent of cardiac cycle. The patient's physiology is monitored, and upon sensing a condition indicative of bradycardia, the delivery of the maintenance dose is suspended.Type: ApplicationFiled: March 15, 2018Publication date: July 19, 2018Applicant: CYBERONICS, INC.Inventors: Imad Libbus, Badri Amurthur, Bruce H. KenKnight
-
Patent number: 10004903Abstract: An implantable neurostimulator-implemented method for managing tachyarrhythmias upon a patient's awakening from sleep through vagus nerve stimulation is provided. An implantable neurostimulator, including a pulse generator, is configured to deliver electrical therapeutic stimulation in a manner that results in creation and propagation (in both afferent and efferent directions) of action potentials within neuronal fibers comprising the cervical vagus nerve of a patient. Operating modes of the pulse generator are stored. An enhanced dose of the electrical therapeutic stimulation is parametrically defined and tuned to prevent initiation of or disrupt tachyarrhythmia upon the patient's awakening from a sleep state through at least one of continuously-cycling, intermittent and periodic ON-OFF cycles of electrical pulses. Other operating modes, including a maintenance dose and a restorative dose are defined.Type: GrantFiled: January 19, 2017Date of Patent: June 26, 2018Assignee: Cyberonics, Inc.Inventors: Imad Libbus, Badri Amurthur, Bruce H. KenKnight
-
Patent number: 9999773Abstract: Multi-modal stimulation therapy may be utilized in which two or more stimulation therapies having different stimulation parameters may be delivered to a single patient. This can preferentially stimulate different nerve fiber types and drive different functional responses in the target organs. The stimulation parameters that may vary between the different stimulation therapies include, for example, pulse frequency, pulse width, pulse amplitude, and duty cycle.Type: GrantFiled: October 22, 2014Date of Patent: June 19, 2018Assignees: Cyberonics, Inc., East Tennessee State UniversityInventors: Imad Libbus, Badri Amurthur, Bruce H. KenKnight, Jeffrey L. Ardell, Gregory A. Ordway
-
Patent number: 9974956Abstract: Methods, systems, and apparatus for quantifying the quality of a fiducial time marker for a candidate heart beat, quantifying the quality of a candidate heart beat, or determining a time of beat sequence of the patient's heart. A fiducial time marker is obtained for a candidate heart beat. A quality index of said candidate heart beat is set to a first value. The candidate heart beat is tested with at least one beat validity test. At least a second value is added to said quality index of said candidate heart beat if said candidate heart beat passes said at least one beat validity test. The candidate heart beat is tested with at least a second heart beat validity test. At least a third value is added to said quality index of said candidate heart beat if said candidate heart beat passes said at least second heart beat validity test.Type: GrantFiled: September 7, 2016Date of Patent: May 22, 2018Assignee: Cyberonics, Inc.Inventors: Mark G Frei, Ivan Osorio
-
Patent number: 9974949Abstract: A medical device includes a pulse generator and a filter. The pulse generator is configured to generate a stimulation signal and to provide the stimulation signal to tissue of a patient via an implantable lead assembly. The filter is configured to couple to the implantable lead assembly. A combined impedance of the implantable lead assembly and the filter with respect to a current induced by an external electro-magnetic field satisfies an impedance threshold when the external electro-magnetic field has a first frequency and when the external electro-magnetic field has a second frequency. The combined impedance has a peak impedance value when the external electro-magnetic field has a third frequency that is between the first frequency and the second frequency.Type: GrantFiled: October 16, 2015Date of Patent: May 22, 2018Assignee: Cyberonics, Inc.Inventors: David L. Thompson, Jason F. Lindh
-
Publication number: 20180126170Abstract: Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. The implanted stimulation device includes a physiological sensor for recording the patient's response to the neurostimulation therapy on an ambulatory basis over extended periods of time.Type: ApplicationFiled: October 13, 2017Publication date: May 10, 2018Applicants: CYBERONICS, INC., EAST TENNESSEE STATE UNIVERSITYInventors: Imad Libbus, Badri Amurthur, Bruce H. KenKnight, Jeffrey L. Ardell
-
Publication number: 20180117333Abstract: Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. The implanted stimulation device includes a physiological sensor for monitoring the patient's response to the neurostimulation therapy on an ambulatory basis over extended periods of time and a control system for adjusting stimulation parameters to maintain stimulation in the neural fulcrum zone based on detected changes in the physiological response to stimulation.Type: ApplicationFiled: November 6, 2017Publication date: May 3, 2018Applicants: CYBERONICS, INC., East Tennessee State UniversityInventors: Imad Libbus, Badri Amurthur, Bruce H. KenKnight, Jeffrey L. Ardell
-
Patent number: 9950169Abstract: Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A computer-implemented control system is operated to automatically identify a neural fulcrum zone based on a monitored patient physiological response. Ongoing neurostimulation therapy is delivered within the neural fulcrum zone.Type: GrantFiled: April 25, 2014Date of Patent: April 24, 2018Assignees: Cyberonics, Inc., East Tennessee State UniversityInventors: Imad Libbus, Badri Amurthur, Bruce H. KenKnight, Jeffrey L. Ardell
-
Patent number: 9943685Abstract: According to aspects of the present disclosure, an implantable electrical system may include an implantable pulse generator with a bore sized to receive an electrical lead, with an engagement mechanism that does not require the use of set screws to secure the lead within the bore. The engagement mechanism may include a deformable component that may be moved or deformed to allow entry of the lead into the bore, and then moved or deformed again to engage a surface of the lead to secure the lead within the bore. The engagement mechanism may allow rotation of the lead within the bore while maintaining electrical connections between the generator and the lead. The engagement mechanism may also allow the securing and/or release of the lead relative to the bore without the need to manipulate a set screw or breach a seal of the generator.Type: GrantFiled: April 23, 2015Date of Patent: April 17, 2018Assignee: Cyberonics, Inc.Inventors: Rajesh Ramesh, David L. Thompson, Steven W. Allis
-
Publication number: 20180099144Abstract: Disclosed herein are methods, systems, and apparatus for treating a medical condition in a patient using an implantable medical device (IMD). The IMD is capable of generating a first electrical signal for treating a medical condition, for example epilepsy. The first electrical signal relates to a long term therapy during a first time period in which there is no indication that the patient's brain is in an stable state, the first electrical signal being a microburst stimulation signal. The implantable device is also capable of generating a second electrical signal for treating the medical condition. The second electrical signal relates to a short term therapy during a second time period, in response to an indication that the patient's brain is in an unstable state. The second electrical signal in one example, may be a conventional stimulation signal.Type: ApplicationFiled: September 29, 2017Publication date: April 12, 2018Applicant: Cyberonics, Inc.Inventor: Timothy L. SCOTT
-
Patent number: 9935498Abstract: A device includes a primary antenna configured to communicate a signal to an antenna of an implantable medical device (IMD). A circulator is coupled to the primary antenna. The circulator enables the signal to pass from a transmitter to the primary antenna. The circulator also enables a backscatter signal from the IMD to pass from the primary antenna to a receiver. A processor coupled to the receiver. The processor configured to determine, based on the backscatter signal, an improved impedance value for a component of the IMD and/or an improved frequency for the signal communicated to the IMD, to improve communication efficiency of the signal to the IMD.Type: GrantFiled: September 25, 2012Date of Patent: April 3, 2018Assignee: Cyberonics, Inc.Inventor: Himanshu Joshi
-
Publication number: 20180078761Abstract: A method including chronically implanting a nerve cuff electrode on a portion of a hypoglossal nerve, chronically implanting a respiration sensing lead subcutaneously in a thorax of a patient, the respiration sensing lead having a plurality of bio-impedance electrodes defining at least one bio-impedance vector. The method may also include sensing a bio-impedance signal corresponding to respiration via a bio-impedance vector on an anterior side of the thorax, analyzing the bio-impedance signal to identify onsets of expiration, predicting an onset of a future expiratory phase, and delivering a stimulus to the portion of the hypoglossal nerve via the nerve cuff electrode, wherein the stimulus is delivered as a function of the bio-impedance signal; wherein stimulus delivery is initiated before the onset of the future expiratory phase and continued during an entire inspiratory phase, and wherein the method is performed without identifying an onset of an inspiratory phase.Type: ApplicationFiled: July 31, 2017Publication date: March 22, 2018Applicant: CYBERONICS, Inc.Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
-
Patent number: 9918670Abstract: A method includes receiving heartbeat data of a patient and receiving activity data of the patient. The activity data includes one or more activity values that are related to an activity level of the patient and that are measured independently of the heartbeat data. The method further includes determining a value of a weighting factor based on the activity data. The method also includes determining modified heartbeat data by applying the weighting factor to at least a portion of the heartbeat data. The method also includes detecting a seizure event based on the modified heartbeat data.Type: GrantFiled: March 3, 2017Date of Patent: March 20, 2018Assignee: Cyberonics, Inc.Inventor: Shivkumar Sabesan
-
Patent number: 9919157Abstract: A method for managing bradycardia through vagus nerve stimulation is provided. An implantable neurostimulator configured to deliver electrical therapeutic stimulation in both afferent and efferent directions of a patient's cervical vagus nerve is provided. An operating mode is stored, which includes parametrically defining a maintenance dose of the electrical therapeutic stimulation tuned to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. The maintenance dose is delivered via a pulse generator through a pair of helical electrodes via an electrically coupled nerve stimulation therapy lead independent of cardiac cycle. The patient's physiology is monitored, and upon sensing a condition indicative of bradycardia, the delivery of the maintenance dose is suspended.Type: GrantFiled: February 11, 2014Date of Patent: March 20, 2018Assignee: Cyberonics, Inc.Inventors: Imad Libbus, Badri Amurthur, Bruce H. KenKnight
-
Patent number: 9913986Abstract: A particular implantable device includes one or more electrode connectors and multiple circuit elements within a housing. The implantable medical device may also include one or more switches, where each switch of the one or more switches is coupled between one or more of the multiple circuit elements and at least one electrode connector of the one or more electrode connectors.Type: GrantFiled: January 14, 2013Date of Patent: March 13, 2018Assignee: Cyberonics, Inc.Inventors: Eric Y. Chow, David L. Thompson
-
Patent number: 9913982Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea. The system is adapted to send an electrical signal from an implanted neurostimulator through a stimulation lead to a patient's nerve at an appropriate phase of the respiratory cycle based on input from a respiration sensing lead. External components are adapted for wireless communication with the neurostimulator. The neurostimulator is adapted to deliver therapeutic stimulation based on inputs.Type: GrantFiled: May 12, 2011Date of Patent: March 13, 2018Assignee: Cyberonics, Inc.Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Wondimeneh Tesfayesus, Jason J. Skubitz, Mark R. Bosshard, Daniel A. Parrish, Robert E. Atkinson
-
Patent number: 9913593Abstract: Medical device systems and methods for operating medical device systems conserve energy by efficiently managing computational demands of the systems. Signals from a subject are processed and analyzed and an estimate of a propensity for a subject to have a neurological event is determined. Based on the results of the analysis and the estimate, further analysis may be performed and the estimate may be refined. Succeeding cycles of signal measurement and analysis are scheduled depending on the results of the analysis and the estimate. The schedule may be varied temporally or with regard to the types and intensities of analyzes performed.Type: GrantFiled: December 27, 2006Date of Patent: March 13, 2018Assignee: Cyberonics, Inc.Inventors: Kent Leyde, John Harris
-
Patent number: 9898656Abstract: The invention provides a method of monitoring a subject's neurological condition. In some embodiments, the method includes the steps of analyzing a physiological signal (such as an EEG) from a subject to determine if the subject is in a contra-ictal condition; and if the subject is in a contra-ictal condition, providing an indication (e.g., to the subject and/or to a caregiver) that the subject is in the contra-ictal condition, such as by activating a green light or other visible output. In some embodiments, if the subject is in a pro-ictal condition, the method includes the step of providing an indication (such as a red light) that the subject is in the pro-ictal condition. The invention also provides neurological system monitors.Type: GrantFiled: January 25, 2008Date of Patent: February 20, 2018Assignee: Cyberonics, Inc.Inventors: David Snyder, Kent W. Leyde, John F. Harris
-
Publication number: 20180028817Abstract: Systems and methods are provided for delivering vagus nerve stimulation and carotid baroreceptor stimulation to patients for treating chronic heart failure and hypertension. The vagus nerve stimulation and carotid baroreceptor stimulation therapies may be provided using a single implantable pulse generator, which can coordinate delivery of the therapies.Type: ApplicationFiled: August 17, 2017Publication date: February 1, 2018Applicant: Cyberonics, Inc.Inventors: Imad LIBBUS, Bruce H. KENKNIGHT, Badri AMURTHUR